Almac Group launches elemental impurities lab 1st February 2018
Almac Group has announced an investment in a state-of-the-art elemental impurities analysis laboratory at their European Headquarters, Craigavon, UK. The company attributes the investment to the new demands that the pharmaceutical industry is currently facing on elemental impurities from regulators stipulating the control and documentation of elemental impurities in drug products, drug substances, and excipients.
The new temperature controlled laboratory will incorporate industry-leading ICP-MS instruments; Thermo iCAP RQ C2 and Agilent 7900, in addition to MARS 5 and 6 microwave digesters.
“With this investment, we are in a position to fully support our global clients in both the pharmaceutical and biopharmaceutical sectors through the challenges of these new regulatory guidelines,” commented Dr Osama Chahrour, leader of ICP-MS Services at Almac Sciences.
“Almac continues to invest heavily in state-of-the-art instruments and laboratories to meet the challenges of new regulations. This enables us to focus on fully supporting our clients through their drug development programs,” added Dr John Malone, analytical manager at Almac Sciences.